Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PLBY
|
Suying Liu
Director |
SELL
Open market or private sale
|
Indirect | 326,492 Reduced 100.0% |
-
|
Oct 02
2020 |
|
PLBY
|
Suying Liu
Director |
SELL
Open market or private sale
|
Indirect | 1,431,450 Reduced 50.55% |
$9,089,707
$6.35 p/Share
|
Oct 02
2020 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.02% |
$2,200
$0.22 p/Share
|
Oct 02
2020 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 1,458 Reduced 0.01% |
$292
$0.2 p/Share
|
Oct 02
2020 |
|
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.52% |
$678,600
$67.86 p/Share
|
Oct 02
2020 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 0.58% |
$775,650
$70.22 p/Share
|
Oct 02
2020 |
|
NKE
|
Philip H Knight |
SELL
Open market or private sale
|
Direct | 800,000 Reduced 19.34% |
$100,247,998
$125.31 p/Share
|
Oct 02
2020 |
|
FNF
|
Raymond R Quirk
Executive Vice-Chairman |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 11.83% |
$1,606,000
$32.12 p/Share
|
Oct 02
2020 |
|
NOVA
|
Ecp Control Co, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,000,000 Reduced 20.07% |
$140,000,000
$28.0 p/Share
|
Oct 02
2020 |
|
RMO
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 206,937 Reduced 3.7% |
$2,363,221
$11.42 p/Share
|
Oct 02
2020 |
|
THRY
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 110,000 Reduced 2.29% |
$1,598,300
$14.53 p/Share
|
Oct 02
2020 |
|
TDOC
|
Andrew Turitz
EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct | 717 Reduced 15.15% |
$161,325
$225.0 p/Share
|
Oct 02
2020 |
|
DDOG
|
Armelle De Madre
Chief People Officer |
SELL
Open market or private sale
|
Direct | 11,250 Reduced 22.43% |
$1,175,850
$104.52 p/Share
|
Oct 02
2020 |
|
TWLO
|
Jeff Lawson
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 22,500 Reduced 28.46% |
$6,187,500
$275.0 p/Share
|
Oct 02
2020 |
|
DPZ
|
Thomas Benjamin Curtis
EVP, U.S. Operations & Support |
SELL
Open market or private sale
|
Direct | 250 Reduced 2.3% |
$108,750
$435.0 p/Share
|
Oct 02
2020 |
|
XYL
|
Markos I Tambakeras |
SELL
Open market or private sale
|
Indirect | 700 Reduced 1.63% |
$59,500
$85.0 p/Share
|
Oct 02
2020 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 17,337 Reduced 0.09% |
$2,841,014
$163.87 p/Share
|
Oct 02
2020 |
|
NBIX
|
Julie Cooke
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 987 Reduced 9.37% |
$94,022
$95.26 p/Share
|
Oct 02
2020 |
|
ZEN
|
John Geschke
Chief of Staff |
SELL
Open market or private sale
|
Direct | 5,500 Reduced 15.35% |
$564,740
$102.68 p/Share
|
Oct 02
2020 |
|
BJ
|
Christopher J Baldwin
Director |
SELL
Open market or private sale
|
Direct | 125,060 Reduced 28.04% |
$5,011,154
$40.07 p/Share
|
Oct 02
2020 |
|
DCI
|
Ajita G Rajendra
Director |
SELL
Open market or private sale
|
Direct | 8,839 Reduced 23.04% |
$424,095
$47.98 p/Share
|
Oct 02
2020 |
|
DCI
|
Ajita G Rajendra
Director |
SELL
Open market or private sale
|
Direct | 22 Reduced 0.06% |
$988
$44.9 p/Share
|
Oct 02
2020 |
|
COLM
|
Sarah Bany
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,000 Reduced 0.23% |
$1,323,600
$88.24 p/Share
|
Oct 02
2020 |
|
AQUA
|
Benedict J. Stas
EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 14,859 Reduced 7.61% |
$326,898
$22.0 p/Share
|
Oct 02
2020 |
|
AQUA
|
Ronald C Keating
President and CEO |
SELL
Open market or private sale
|
Direct | 6,095 Reduced 1.29% |
$134,090
$22.0 p/Share
|
Oct 02
2020 |
|
RPD
|
Thomas E Schodorf
Director |
SELL
Open market or private sale
|
Direct | 250 Reduced 0.91% |
$14,988
$59.95 p/Share
|
Oct 02
2020 |
|
CARG
|
Thomas Michael Caputo
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 1,879 Reduced 0.89% |
$41,357
$22.01 p/Share
|
Oct 02
2020 |
|
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Direct | 12,006 Reduced 1.24% |
$264,252
$22.01 p/Share
|
Oct 02
2020 |
|
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Indirect | 987 Reduced 0.89% |
$21,724
$22.01 p/Share
|
Oct 02
2020 |
|
NOVA
|
Michael P Grasso
Officer |
SELL
Open market or private sale
|
Direct | 26,402 Reduced 99.83% |
$811,862
$30.75 p/Share
|
Oct 02
2020 |
|
HNI
|
Steven M Bradford
Sr. VP, Gen. Counsel & Sec. |
SELL
Open market or private sale
|
Direct | 7,812 Reduced 18.52% |
$265,608
$34.0 p/Share
|
Oct 02
2020 |
|
FSLY
|
Joshua Bixby
CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 6.18% |
$1,978,000
$98.9 p/Share
|
Oct 02
2020 |
|
GBX
|
Mark J Rittenbaum
EVP, Chief Comm & Leasing Off |
SELL
Open market or private sale
|
Direct | 2,016 Reduced 3.16% |
$62,436
$30.97 p/Share
|
Oct 02
2020 |
|
RDFN
|
Bridget Frey
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.51% |
$251,450
$50.29 p/Share
|
Oct 02
2020 |
|
CSTL
|
David S Kabakoff
Director |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 2.42% |
$1,301,750
$52.07 p/Share
|
Oct 02
2020 |
|
SFIX
|
Scott Darling
Chief Legal Officer & Secr. |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 2.86% |
$54,760
$27.38 p/Share
|
Oct 02
2020 |
|
BLUE
|
David Davidson
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 64 Reduced 0.16% |
$3,377
$52.77 p/Share
|
Oct 02
2020 |
|
BLUE
|
Jason Cole
Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct | 38 Reduced 0.11% |
$2,005
$52.77 p/Share
|
Oct 02
2020 |
|
BLUE
|
Joanne Smith Farrell
COO, Oncology |
SELL
Open market or private sale
|
Direct | 38 Reduced 0.17% |
$2,005
$52.77 p/Share
|
Oct 02
2020 |
|
BLUE
|
Alison Cecily Finger
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 36 Reduced 0.13% |
$1,900
$52.77 p/Share
|
Oct 02
2020 |
|
BLUE
|
Nick Leschly |
SELL
Open market or private sale
|
Direct | 450 Reduced 0.45% |
$23,747
$52.77 p/Share
|
Oct 02
2020 |
|
BLUE
|
Philip D Gregory
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 60 Reduced 0.17% |
$3,166
$52.77 p/Share
|
Oct 02
2020 |
|
ARAY
|
Joshua Levine
CEO |
SELL
Open market or private sale
|
Direct | 15,370 Reduced 1.97% |
$37,349
$2.43 p/Share
|
Oct 02
2020 |
|
ARAY
|
Shigeyuki Hamamatsu
SVP & CFO |
SELL
Open market or private sale
|
Direct | 8,641 Reduced 4.65% |
$20,998
$2.43 p/Share
|
Oct 02
2020 |
|
HOOK
|
Capital Vi Fcpr Sofinnova
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.01% |
$3,000
$10.0 p/Share
|
Oct 02
2020 |
|
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct | 4,667 Reduced 10.66% |
$1,306,760
$280.0 p/Share
|
Oct 02
2020 |
|
EPAY
|
Nigel K Savory
Managing Director Europe |
SELL
Open market or private sale
|
Direct | 1,442 Reduced 0.88% |
$60,766
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
John Francis Kelly
GM, Legal Solutions |
SELL
Open market or private sale
|
Direct | 326 Reduced 0.53% |
$13,738
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
Robert A Eberle
President & CEO |
SELL
Open market or private sale
|
Direct | 5,209 Reduced 1.13% |
$219,507
$42.14 p/Share
|
Oct 02
2020 |
|
EPAY
|
Norman J Deluca
MD of Banking Solutions |
SELL
Open market or private sale
|
Direct | 870 Reduced 0.91% |
$36,662
$42.14 p/Share
|
Oct 02
2020 |